Hiring in life sciences? Share your open positions with our professional community. Read more Close

Your cookie settings

This site uses cookies. Some cookies are essential to make the site work and others help us to improve our services. Read more about cookies in our Privacy policy.

Choose your cookie preferences:

Advertisement

Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes.

Created on 12 Jun 2025

Authors

Marlise R Luskin, Jessica T Leonard

Published in

Haematologica. Jun 12, 2025. Epub Jun 12, 2025.

Abstract

Not available.

PMID:
40501389
Bibliographic data and abstract were imported from PubMed on 12 Jun 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Sign in to post a review. Add review
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 15
  • Comments 0

Recommended by

  • No recommendations yet.

Do you recommend this? Please sign in. Yes No

Recommended

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement